Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Report 2024

Generative Artificial Intelligence (AI) In Pharmaceutical Global Market Report 2024 – By Type (Small Molecule, Large Molecule), By Technology (Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies), By Application (Clinical Trial Research, Drug Discovery, Research And Development, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

Generative Artificial Intelligence (AI) In Pharmaceutical Global Market Report 2024

Starting Price : $4000.00 $3200.00 | Pages : 175 | Published : November 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Global Generative Artificial Intelligence AI In Pharmaceutical Market Infographic

Proud Members Of

checkslacipN checkaoirsN checkscipN

Generative Artificial Intelligence (AI) In Pharmaceutical Market Definition

Generative artificial intelligence (AI) in pharmaceuticals leverages advanced algorithms and machine learning to design new drug compounds, predict molecular behaviors, and optimize drug discovery processes. It uses techniques such as Deep Learning and generative adversarial networks (GANs) to create novel molecular structures and simulate their interactions.

The main types of generative artificial intelligence (AI) in pharmaceuticals are small molecules and large molecules. Small-molecule drugs are low-molecular-weight compounds that can easily enter cells and affect biological processes. The various technologies include deep learning, natural language processing, querying methods, context-aware processing, and others for varying applications such as clinical trial research, drug discovery, research and development, and others.

Generative Artificial Intelligence (AI) In Pharmaceutical Market Segmentation

The generative artificial intelligence (AI) in pharmaceutical market covered in this report is segmented –

1) By Type: Small Molecule, Large Molecule

2) By Technology: Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies

3) By Application: Clinical Trial Research, Drug Discovery, Research And Development, Other Applications

Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Size 2023 to 2028: Graph

Generative Artificial Intelligence (AI) In Pharmaceutical Market Size 2024 And Growth Rate

The generative artificial intelligence (AI) in the pharmaceutical market size has grown exponentially in recent years. It will grow from $1.41 billion in 2023 to $1.85 billion in 2024 at a compound annual growth rate (CAGR) of 31%. The growth in the historic period can be attributed to growth in computational power, the rise of big data in healthcare and pharmaceuticals, increased research and development investment, improved data quality and integration, and expansion of cloud computing.

Generative Artificial Intelligence (AI) In Pharmaceutical Market Growth Forecast

The generative artificial intelligence (AI) in the pharmaceutical market size is expected to see exponential growth in the next few years. It will grow to $5.47 billion in 2028 at a compound annual growth rate (CAGR) of 31.1%. The growth in the forecast period can be attributed to a focus on early disease detection, regulatory support, and guidelines, improved computational power, growth in drug development costs, increased data availability. Major trends in the forecast period include blockchain and AI integration, advanced data integration, enhanced disease diagnosis, automated drug repurposing, real-time clinical trial optimization.

Generative Artificial Intelligence (AI) In Pharmaceutical Market Driver: Rising Emphasis On Personalized Medicine Drive Generative AI In Pharmaceutical Market

The increasing focus on personalized medicine is expected to propel the growth of generative artificial intelligence (AI) in the pharmaceutical market going forward. Personalized medicine tailors medical treatment to the individual characteristics, needs, and preferences of each patient based on genetic, environmental, and lifestyle factors. The focus on personalized medicine is increasing due to advancements in genetic research and technology, enabling more precise and effective treatments tailored to individual patients. Personalized medicine leverages generative AI in pharmaceuticals to develop tailored drug therapies, improving treatment efficacy and patient outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the increasing focus on personalized medicine is driving the growth of generative artificial intelligence (AI) in the pharmaceutical market.

Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Major Players

Major companies operating in the generative artificial intelligence (AI) in pharmaceutical market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc., Numerate Inc., Atomwise Inc., BenevolentAI Limited

Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Trend: Advancements In Drug Discovery With Generative AI

Major companies operating in generative artificial intelligence (AI) in pharmaceutical market are developing new products, such as AI healthcare microservices, to streamline drug discovery processes. AI healthcare microservices are modular, cloud-based services that use artificial intelligence to improve healthcare functions such as drug discovery, medical imaging, and diagnostics. For instance, in March 2024, Nvidia Corporation, a US-based technology company, launched generative AI microservices. It features optimized NIM AI models and workflows with APIs for building cloud-native applications. It provides advanced imaging, natural language, and speech recognition, along with digital biology capabilities. The key tools included are Parabricks, MONAI, NeMo, Riva, and Metropolis are accessible as CUDA-X microservices, enhancing workflows in drug discovery and genomics.

Generative Artificial Intelligence (AI) In Pharmaceutical Market Merger And Acquisition: Eli Lilly Collaborated With XtalPi For AI Drug Discovery

In June 2023, Eli Lilly and Company, a US-based company engaged in research-based pharmaceutical and biomedical research, collaborated with XtalPi Inc. The partnership will use XtalPi’s advanced AI-driven drug discovery platform, ID4Inno, to design and develop drug candidates targeting a specific, undisclosed goal. This collaboration aims to leverage XtalPi's technology to explore extensive chemical spaces and identify promising drug candidates through a process of iterative design, synthesis, testing, and analysis, all supported by autonomous robotic systems to ensure efficiency and precision. XtalPi Inc. is a China-based AI-powered drug research and development company.

Regional Insights For The Global Generative Artificial Intelligence (AI) In Pharmaceutical Market

North America was the largest region in the generative artificial intelligence (AI) in the pharmaceutical market in 2023. The regions covered in the generative artificial intelligence (AI) in pharmaceutical market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the generative artificial intelligence (AI) in pharmaceutical market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative artificial intelligence (AI) in pharmaceutical market includes revenues earned by entities through drug design, clinical trial optimization, biomarker discovery, and virtual screening. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The generative artificial intelligence (AI) in pharmaceutical market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) in pharmaceutical market statistics, including generative artificial intelligence (AI) in pharmaceutical industry global market size, regional shares, competitors with a generative artificial intelligence (AI) in pharmaceutical market share, detailed generative artificial intelligence (AI) in pharmaceutical market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) in pharmaceutical industry. This generative artificial intelligence (AI) in pharmaceutical market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Generative Artificial Intelligence (AI) In Pharmaceutical Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2024 $ 3.11 Billion
Revenue Forecast In 2033 $ 4.22 Billion
Growth Rate CAGR of 8.00% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Small Molecule, Large Molecule
2) By Technology: Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies
3) By Application: Clinical Trial Research, Drug Discovery, Research And Development, Other Applications
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc., Numerate Inc., Atomwise Inc., BenevolentAI Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Generative Artificial Intelligence (AI) In Pharmaceutical Market Characteristics

    3. Generative Artificial Intelligence (AI) In Pharmaceutical Market Trends And Strategies

    4. Generative Artificial Intelligence (AI) In Pharmaceutical Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Size and Growth

    5.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Generative Artificial Intelligence (AI) In Pharmaceutical Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Generative Artificial Intelligence (AI) In Pharmaceutical Market Segmentation

    6.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Small Molecule

    Large Molecule

    6.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Deep Learning

    Natural Language Processing

    Querying Method

    Context-Aware Processing

    Other Technologies

    6.3. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Clinical Trial Research

    Drug Discovery

    Research And Development

    Other Applications

    7. Generative Artificial Intelligence (AI) In Pharmaceutical Market Regional And Country Analysis

    7.1. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market

    8.1. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Generative Artificial Intelligence (AI) In Pharmaceutical Market

    9.1. China Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

    9.2. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Generative Artificial Intelligence (AI) In Pharmaceutical Market

    10.1. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market

    11.1. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

    11.2. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market

    12.1. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market

    13.1. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market

    14.1. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

    14.2. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market

    15.1. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

    15.2. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market

    16.1. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market

    17.1. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Generative Artificial Intelligence (AI) In Pharmaceutical Market

    18.1. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market

    19.1. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market

    20.1. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market

    21.1. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

    21.2. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market

    22.1. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market

    23.1. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

    23.2. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market

    24.1. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

    24.2. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market

    25.1. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

    25.2. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market

    26.1. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

    26.2. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market

    27.1. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market

    28.1. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

    28.2. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market

    29.1. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market Overview

    29.2. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Landscape And Company Profiles

    30.1. Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Landscape

    30.2. Generative Artificial Intelligence (AI) In Pharmaceutical Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson & Johnson

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Roche Holding AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Merck & Co. Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. AbbVie Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Generative Artificial Intelligence (AI) In Pharmaceutical Market Other Major And Innovative Companies

    31.1. Bayer AG

    31.2. Sanofi S.A.

    31.3. Bristol-Myers Squibb Company

    31.4. AstraZeneca PLC

    31.5. Novartis AG

    31.6. GlaxoSmithKline plc

    31.7. Fujitsu Limited

    31.8. Takeda Pharmaceutical Company Limited

    31.9. Eli Lilly and Company

    31.10. Amgen Inc.

    31.11. Gilead Sciences Inc.

    31.12. NVIDIA Corporation

    31.13. Conduent Incorporated

    31.14. XtalPi Inc.

    31.15. Insilico Medicine Inc.

    32. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Benchmarking

    33. Global Generative Artificial Intelligence (AI) In Pharmaceutical Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Pharmaceutical Market

    35. Generative Artificial Intelligence (AI) In Pharmaceutical Market Future Outlook and Potential Analysis

    35.1 Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2028 - Countries Offering Most New Opportunities

    35.2 Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2028 - Segments Offering Most New Opportunities

    35.3 Generative Artificial Intelligence (AI) In Pharmaceutical Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Pfizer Inc. Financial Performance
  • Figure 75: Johnson & Johnson Financial Performance
  • Figure 76: Roche Holding AG Financial Performance
  • Figure 77: Merck & Co. Inc. Financial Performance
  • Figure 78: AbbVie Inc. Financial Performance

List Of Figures

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Generative Artificial Intelligence (AI) In Pharmaceutical Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Generative Artificial Intelligence (AI) In Pharmaceutical Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Pfizer Inc. Financial Performance
  • Table 75: Johnson & Johnson Financial Performance
  • Table 76: Roche Holding AG Financial Performance
  • Table 77: Merck & Co. Inc. Financial Performance
  • Table 78: AbbVie Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the generative artificial intelligence (AI) in pharmaceutical market?

Generative artificial intelligence (AI) in pharmaceuticals leverages advanced algorithms and machine learning to design new drug compounds, predict molecular behaviors, and optimize drug discovery processes. It uses techniques such as deep learning and generative adversarial networks (GANs) to create novel molecular structures and simulate their interactions. For further insights on the generative artificial intelligence (AI) in pharmaceutical market, request a sample here

How will the generative artificial intelligence (AI) in pharmaceutical market drivers and restraints affect the generative artificial intelligence (AI) in pharmaceutical market dynamics? What forces will shape the generative artificial intelligence (AI) i

The generative artificial intelligence (AI) in pharmaceutical market major growth driver - Rising Emphasis On Personalized Medicine Drive Generative AI In Pharmaceutical Market. For further insights on the generative artificial intelligence (AI) in pharma request a sample here

What is the forecast market size or the forecast market value of the generative artificial intelligence (AI) in pharmaceutical market?

The generative artificial intelligence (AI) in the pharmaceutical market size has grown exponentially in recent years. It will grow from $1.41 billion in 2023 to $1.85 billion in 2024 at a compound annual growth rate (CAGR) of 31%. The growth in the historic period can be attributed to growth in computational power, the rise of big data in healthcare and pharmaceuticals, increased research and development investment, improved data quality and integration, and expansion of cloud computing. The generative artificial intelligence (AI) in the pharmaceutical market size is expected to see exponential growth in the next few years. It will grow to $5.47 billion in 2028 at a compound annual growth rate (CAGR) of 31.1%. The growth in the forecast period can be attributed to a focus on early disease detection, regulatory support, and guidelines, improved computational power, growth in drug development costs, increased data availability. Major trends in the forecast period include blockchain and AI integration, advanced data integration, enhanced disease diagnosis, automated drug repurposing, real-time clinical trial optimization. For further insights on the generative artificial intelligence (AI) in pharmaceutical market, request a sample here

How is the generative artificial intelligence (AI) in pharmaceutical market segmented?

The generative artificial intelligence (AI) in pharmaceutical market is segmented
1) By Type: Small Molecule, Large Molecule
2) By Technology: Deep Learning, Natural Language Processing, Querying Method, Context-Aware Processing, Other Technologies
3) By Application: Clinical Trial Research, Drug Discovery, Research And Development, Other Applications For further insights on the generative artificial intelligence (AI) in pharmaceutical market,
request a sample here

Which region has the largest share of the generative artificial intelligence (AI) in pharmaceutical market? What are the other regions covered in the report?

North America was the largest region in the generative artificial intelligence (AI) in the pharmaceutical market in 2023. The regions covered in the generative artificial intelligence (AI) in pharmaceutical market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the generative artificial intelligence (AI) in pharmaceutical market, request a sample here.

Who are the major players in the generative artificial intelligence (AI) in pharmaceutical market?

Major companies operating in the generative artificial intelligence (AI) in pharmaceutical market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Fujitsu Limited, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., NVIDIA Corporation, Conduent Incorporated, XtalPi Inc., Insilico Medicine Inc., Numerate Inc., Atomwise Inc., BenevolentAI Limited For further insights on the generative artificial intelligence (AI) in pharmaceutical market, request a sample here.

What are the key trends in the generative artificial intelligence (AI) in pharmaceutical market?

Major trend in the generative artificial intelligence (AI) in pharmaceutical market - Advancements In Drug Discovery With Generative AI. For further insights on the generative artificial intelligence (AI) in pharmaceutical market, request a sample here.

What are the major opportunities in the generative artificial intelligence (AI) in pharmaceutical market? What are the strategies for the generative artificial intelligence (AI) in pharmaceutical market?

For detailed insights on the major opportunities and strategies in the generative artificial intelligence (AI) in pharmaceutical market, request a sample here.

How does the generative artificial intelligence (AI) in pharmaceutical market relate to the overall economy and other similar markets?

For detailed insights on generative artificial intelligence (AI) in pharmaceutical market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the generative artificial intelligence (AI) in pharmaceutical industry?

For detailed insights on the mergers and acquisitions in the generative artificial intelligence (AI) in pharmaceutical industry, request a sample here.

What are the key dynamics influencing the generative artificial intelligence (AI) in pharmaceutical market growth? SWOT analysis of the generative artificial intelligence (AI) in pharmaceutical market.

For detailed insights on the key dynamics influencing the generative artificial intelligence (AI) in pharmaceutical market growth and SWOT analysis of the generative artificial intelligence (AI) in pharmaceutical industry, request a sample here.